Trial Profile
SMC021A - absorption, efficacy and tolerance in patients with osteoarthritis. A placebo-controlled 14-days study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Calcitonin (Primary)
- Indications Osteoarthritis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Nordic Bioscience
- 01 Feb 2010 Results published in Osteoarthritis and Cartilage.
- 16 Oct 2009 Results were reported in an Emisphere Technologies media release.
- 06 Jul 2007 New trial record.